Literature DB >> 12427462

Plasmodium falciparum: in vitro activity of sulfadoxine and dapsone in field isolates from Kenya: point mutations in dihydropteroate synthase may not be the only determinants in sulfa resistance.

Edward K Mberu1, Alexis M Nzila, Eunice Nduati, Amanda Ross, Stephanie M Monks, Gilbert O Kokwaro, William M Watkins, Carol Hopkins Sibley.   

Abstract

We have determined the relationship between point mutations in the gene that encodes the sulfa target, dihydropteroate synthase (DHPS) and the chemosensitivity profile to sulfadoxine and dapsone in 67 isolates from Kilifi, Kenya. We assessed the presence of mutations at codons 436, 437, 540, 581, and 613 of dhps. The results showed that the dhps genotype had a strong influence on the sensitivity to sulfadoxine and dapsone, but that the correlation was far from perfect. Eleven isolates carried a wild-type dhps allele, but were resistant to sulfadoxine (IC(50) values >10 microg/ml), and 4/28 isolates were classed as sensitive to sulfadoxine (IC(50) values <10 microg/ml), but carried a triple mutant (436/437/613) allele of dhps. These data show that in low folate medium in vitro, the dhps genotype alone did not account completely for sulfadoxine or dapsone resistance; other factors such as the utilisation of exogenous folate must also be considered.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12427462     DOI: 10.1016/s0014-4894(02)00108-x

Source DB:  PubMed          Journal:  Exp Parasitol        ISSN: 0014-4894            Impact factor:   2.011


  7 in total

1.  Drug susceptibility and genetic evaluation of Plasmodium falciparum isolates obtained in four distinct geographical regions of Kenya.

Authors:  Abigael Mbaisi; Pamela Liyala; Fredrick Eyase; Rachel Achilla; Hosea Akala; Julia Wangui; Josphat Mwangi; Finnley Osuna; Uzma Alam; Bonnie L Smoak; Jon M Davis; Dennis E Kyle; Rodney L Coldren; Carl Mason; Norman C Waters
Journal:  Antimicrob Agents Chemother       Date:  2004-09       Impact factor: 5.191

Review 2.  Exploring the folate pathway in Plasmodium falciparum.

Authors:  John E Hyde
Journal:  Acta Trop       Date:  2005-04-18       Impact factor: 3.112

Review 3.  Targeting purine and pyrimidine metabolism in human apicomplexan parasites.

Authors:  John E Hyde
Journal:  Curr Drug Targets       Date:  2007-01       Impact factor: 3.465

4.  Dihydropteroate synthase mutations in Pneumocystis jiroveci can affect sulfamethoxazole resistance in a Saccharomyces cerevisiae model.

Authors:  Peter Iliades; Steven R Meshnick; Ian G Macreadie
Journal:  Antimicrob Agents Chemother       Date:  2004-07       Impact factor: 5.191

5.  Plasmodium falciparum isolates in India exhibit a progressive increase in mutations associated with sulfadoxine-pyrimethamine resistance.

Authors:  Anwar Ahmed; Deepak Bararia; Sumiti Vinayak; Mohammed Yameen; Sukla Biswas; Vas Dev; Ashwani Kumar; Musharraf A Ansari; Yagya D Sharma
Journal:  Antimicrob Agents Chemother       Date:  2004-03       Impact factor: 5.191

6.  Increased prevalence of the pfdhfr/phdhps quintuple mutant and rapid emergence of pfdhps resistance mutations at codons 581 and 613 in Kisumu, Kenya.

Authors:  Maroya D Spalding; Fredrick L Eyase; Hoseah M Akala; Sheryl A Bedno; Sean T Prigge; Rodney L Coldren; William J Moss; Norman C Waters
Journal:  Malar J       Date:  2010-11-24       Impact factor: 2.979

7.  Chemoprophylaxis and malaria death rates.

Authors:  Gérard Krause; Irene Schöneberg; Doris Altmann; Klaus Stark
Journal:  Emerg Infect Dis       Date:  2006-03       Impact factor: 6.883

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.